CLLK.F Stock Overview
Operates as a bioconvergence company in North America, Europe, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BICO Group AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 3.01 |
| 52 Week High | SEK 6.90 |
| 52 Week Low | SEK 3.01 |
| Beta | 2.38 |
| 11 Month Change | -18.75% |
| 3 Month Change | -31.12% |
| 1 Year Change | -29.18% |
| 33 Year Change | -91.00% |
| 5 Year Change | -89.93% |
| Change since IPO | -78.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLLK.F | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -9.3% | 2.8% | 2.2% |
| 1Y | -29.2% | 2.9% | 31.6% |
Return vs Industry: CLLK.F underperformed the US Life Sciences industry which returned 2.9% over the past year.
Return vs Market: CLLK.F underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| CLLK.F volatility | |
|---|---|
| CLLK.F Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 8.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CLLK.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CLLK.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 832 | Maria Forss | www.bico.com |
BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing.
BICO Group AB (publ) Fundamentals Summary
| CLLK.F fundamental statistics | |
|---|---|
| Market cap | US$232.62m |
| Earnings (TTM) | -US$135.68m |
| Revenue (TTM) | US$219.45m |
1.1x
P/S Ratio-1.7x
P/E RatioIs CLLK.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLLK.F income statement (TTM) | |
|---|---|
| Revenue | SEK 2.42b |
| Cost of Revenue | SEK 684.50m |
| Gross Profit | SEK 1.74b |
| Other Expenses | SEK 3.24b |
| Earnings | -SEK 1.50b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 26, 2024
| Earnings per share (EPS) | -21.23 |
| Gross Margin | 71.75% |
| Net Profit Margin | -61.83% |
| Debt/Equity Ratio | 48.6% |
How did CLLK.F perform over the long term?
See historical performance and comparison